Agency: NIH/HNRC
Agency Award Number: HNRC859

This study will help determine the role of epigenetic alterations in the regulation of the latency of HIV in the human brain.

Agency: NIH/NIMH
Agency Award Number: R01MH058076

To evaluate the efficacy of a CNS-targeted antiretroviral treatment (ART) strategy for individuals with HIV-associated neurocognitive impairment (HNCI) through a randomized clinical trial.

Agency: NIH/NIMH
Agency Award Number: R21MH76651

To perform a cross-sectional comparison of the influence of HIV-1 clade on neurocognitive and neurological disorders in southern Brazil.

Agency: NIH/NIDA
Agency Award Number: R21DA027273

To investigate the relationship between the inherited genotype of catechol-o-methyl transferase (COMT) and the protection against the development of HIV related impaired executive function, which is lost when methamphetamine (METH) is used by the affected individuals.

Agency: NIH/NIMH
Agency Award Number: R25MH071482

To establish a two-year Interdisciplinary Research Fellowship in NeuroAIDS to train tomorrow`s generation of NeuroAIDS clinician-researchers by mentoring fellows with leading edge basic and clinical neuroscientists attached to the HNRC, UCSD, The Scripps Research Institute, and the Burnham Medical Research Institute.

Agency: NIH/NIMH
Agency Award Number: R01MH079881

To quantify our candidate somatostatin and stress-related gene expression in human brain derived from persons who died with HIV, MDD and combined risks, as well as those who had neither risk, and to establish whether commonalities exist between HIV and MDD at the gene expression level.